Paediatric Keratoconus: An ERN-EYE Clinical Consensus Statement on Diagnosis, Treatment and Follow-Up Care

Luca Buzzonetti1, Cosimo Mazzotta2,3,4, Michele Iester5,6

  • 1ERN-EYE, Ophthalmology Unit, Bambino Gesù IRCCS Children's Hospital, Piazza Sant'Onofrio 4, 00165, Rome, Italy. luca.buzzonetti@opbg.net.

Insights

This consensus statement offers crucial guidance for diagnosing, monitoring, and managing pediatric keratoconus, a progressive eye condition in children. It aims to standardize care and improve visual development outcomes for affected youth.

Area of Science:

  • Ophthalmology
  • Pediatric Eye Care
  • Corneal Ectasias

Background:

  • Pediatric keratoconus is a rapidly progressing corneal ectasia affecting children and adolescents.
  • Lack of standardized, pediatric-specific guidelines hinders optimal management.
  • Early detection and intervention are critical for visual development.

Purpose of the Study:

  • To provide evidence-based recommendations for pediatric keratoconus diagnosis, monitoring, and management.
  • To address the need for standardized, multidisciplinary care guidelines.
  • To guide European healthcare professionals in managing pediatric keratoconus.

Main Methods:

  • A clinical consensus statement developed via a structured Delphi process.
  • Involved a multidisciplinary panel of European experts from ERN-EYE.
  • Comprehensive review of current understanding, diagnostics, risk factors, and treatments.

Main Results:

  • Consensus on physiopathology, diagnostic criteria, and classification systems for pediatric keratoconus.
  • Outlined strategies for early detection and continuous monitoring.
  • Presented current treatment approaches with pediatric-specific recommendations.

Conclusions:

  • The statement provides essential guidance for ophthalmologists, pediatricians, and allied health professionals.
  • Aims to improve the timely and appropriate care of children with keratoconus.
  • Standardized management is expected to enhance visual outcomes across Europe.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...